Director
DIN: 07866501
Bhavika Penchala is currently associated with 4 companies in various capacities such as Director, Individual Promoter, Designated Partner and Individual Subscriber. They serve as a Director at SIMSON PHARMA LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07866501.Bhavika Penchala is currently involved in 4 different roles. Their most recent position is with AMMA AYEE SEVA FOUNDATION as a Individual Subscriber. The first company Bhavika Penchala was appointed to as a director was SIMSON PHARMA LIMITED. Bhavika Penchala is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Bhavika Penchala is currently associated with 4 companies in various capacities such as Director, Individual Promoter, Designated Partner and Individual Subscriber. They serve as a Director at SIMSON PHARMA LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07866501.Bhavika Penchala is currently involved in 4 different roles. Their most recent position is with AMMA AYEE SEVA FOUNDATION as a Individual Subscriber. The first company Bhavika Penchala was appointed to as a director was SIMSON PHARMA LIMITED. Bhavika Penchala is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
5
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (3)
Current LLPs (1)
Past Companies (0)
1y 8m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SIMSON PHARMA LIMITED | Director | 19-Apr-2018 |
| SIMSON PHARMA LIMITED | Individual Promoter | 19-Apr-2018 |
| HEALTHTECH SOLUTIONS PRIVATE LIMITED | Director | 06-Dec-2025 |
| AMMA AYEE SEVA FOUNDATION | Individual Subscriber | 29-Dec-2025 |